Clinical studies recruiting near Chattanooga

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart
Phase 3 · CON-10051, Chattanooga, TN · Colorado Prevention Center · NCT06024746 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Tennessee Oncology, PLLC - Chattanooga Downtown · Pfizer · NCT07028853 A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Tennessee Oncology-Chattanooga ( Site 0045) · Merck Sharp & Dohme LLC · NCT06136559 A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Phase 3 · WR-ClinSearch, LLC · Kallyope Inc. · NCT07674654 PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Phase 2 · Southeast Renal Research Institute · Boehringer Ingelheim · NCT07355296 Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Phase 1/Phase 2 · Tennessee Oncology, PLLC - Chattanooga Downtown · Pfizer · NCT07421700 A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis
Phase 4 · Erlanger Neuroscience Institute · argenx · NCT06909214 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Tennessee Oncology Chattanooga · Eli Lilly and Company · NCT06890598 Non-Invasive Preeclampsia Screening and Biobank
Phase N/A · Chattanooga Medical Research · Sequenom, Inc. · NCT06643741 A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · T C Thompson Children's Hospital · Children's Oncology Group · NCT04322318 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Tennessee Oncology, PLLC - Chattanooga Downtown · Pfizer · NCT07144280 An Open-Label, Single-Arm Study to Investigate the Efficacy and Safety of North Star Desiccated Porcine Thyroid Extract
Phase 3 · M3 Wake Research · Neuvosyn Laboratories, LLC · NCT07747103 A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · Greco-Hainsworth Centers for Research ( Site 4034) · Merck Sharp & Dohme LLC · NCT06077760 A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Phase 1/Phase 2 · Tennessee Oncology, PLLC · Artios Pharma Ltd · NCT04657068 A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic So
Phase 1/Phase 2 · Erlanger Health, Inc · Daiichi Sankyo · NCT06330064 Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix Breast Reconstruction (ADORA) in Adult
Phase 3 · Erlanger Health System /ID# 266608 · AbbVie · NCT06575192 A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosc
Phase 3 · Southeast Renal Research Institute · Boehringer Ingelheim · NCT07220083 RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
Phase N/A · Cyberknife at Erlanger · The Radiosurgery Society · NCT01885299 A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung C
Phase 3 · Tennessee Oncology, PLLC - Chattanooga Downtown ( Site 0315) · Merck Sharp & Dohme LLC · NCT06623422 Pan Tumor Rollover Study
Phase 2 · Local Institution · Bristol-Myers Squibb · NCT03899155 A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06692738 Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC Wi
Phase 3 · Research Site · AstraZeneca · NCT06357533 A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary H
Phase 2/Phase 3 · Chattanooga Medical Research /ID# 257631 · AbbVie · NCT06345339 Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Phase 1/Phase 2 · Tennessee Oncology · Revolution Medicines, Inc. · NCT05379985 A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed A
Phase 3 · T C Thompson Children's Hospital · Children's Oncology Group · NCT04293562 The THOR IDE Study
NA · Vascular Institute of Chattanooga · Philips Clinical & Medical Affairs Global · NCT05916950 A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis
Phase 2 · Ut Erlanger Neurology · Vertex Pharmaceuticals Incorporated · NCT07501702 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557 Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Antica
Phase 1/Phase 2 · Tennessee Oncology, PLLC- Chattanooga Downtown · Pfizer · NCT07227415 A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants Wi
Phase 3 · Research Site · AstraZeneca · NCT05211895

Look up another city

Look up another condition